BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35138462)

  • 1. Correlation between
    Liu X; Wang SC; Ni M; Xie Q; Zhang YF; Lv WF; Geng GY
    Abdom Radiol (NY); 2022 Apr; 47(4):1255-1264. PubMed ID: 35138462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of
    Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
    Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between KRAS mutation and
    Cho A; Jo K; Hwang SH; Lee N; Jung M; Yun M; Hwang HS
    Abdom Radiol (NY); 2017 Jun; 42(6):1621-1626. PubMed ID: 28161825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Intratumor Metabolic Heterogeneity Parameters on
    Liu X; Xiang K; Geng GY; Wang SC; Ni M; Zhang YF; Pan HF; Lv WF
    Contrast Media Mol Imaging; 2022; 2022():2586245. PubMed ID: 35173559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by
    Ikeno Y; Seo S; Iwaisako K; Yoh T; Nakamoto Y; Fuji H; Taura K; Okajima H; Kaido T; Sakaguchi S; Uemoto S
    J Transl Med; 2018 Apr; 16(1):95. PubMed ID: 29642912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
    Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
    J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
    Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between KRAS mutations and dual time point
    Mao W; Zhou J; Zhang H; Qiu L; Tan H; Hu Y; Shi H
    Abdom Radiol (NY); 2019 Jun; 44(6):2059-2066. PubMed ID: 30143816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlations of
    Wang JL; Shi AQ; Fan CC; Wang YZ; Guo GR; Liu JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):628-635. PubMed ID: 36065696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activity via
    Song J; Li Z; Yang L; Wei M; Yang Z; Wang X
    BMC Cancer; 2022 Jul; 22(1):808. PubMed ID: 35869469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
    Chen SW; Chiang HC; Chen WT; Hsieh TC; Yen KY; Chiang SF; Kao CH
    Clin Nucl Med; 2014 Aug; 39(8):685-9. PubMed ID: 24978328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
    Krikelis D; Skoura E; Kotoula V; Rondogianni P; Pianou N; Samartzis A; Xanthakis I; Fountzilas G; Datseris IE
    Anticancer Res; 2014 May; 34(5):2571-9. PubMed ID: 24778079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
    Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
    Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY; Guo Z; Sun J; Yang WP; Li TR
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Wu X; Huang Y; Li Y; Wang Q; Wang H; Jiang L
    Ann Nucl Med; 2019 Sep; 33(9):647-656. PubMed ID: 31165974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
    Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
    J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-tumor metabolic heterogeneity of gastric cancer on
    Liu G; Yin H; Cheng X; Wang Y; Hu Y; Liu T; Shi H
    Clin Exp Med; 2021 Feb; 21(1):129-138. PubMed ID: 32880779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.